CRISPR Gene-Editing Tool Used To Treat First U.S. Patient

For the first time in the U.S., a patient has received an infusion of 2 billion cells edited with the gene-editing tool CRISPR to help treat sickle cell disease, presaging a new age of targeted treatments for genetic diseases. What do you think?

“Would it really have been that hard to figure out a way to add an ‘e’ to the acronym?”

Alysha Phelps • Infomercial Extra


“This sounds like some techno-dystopia where people don’t have to have cystic fibrosis.”

Ramone Pritchard • Sweat Lodge Janitor

“Hopefully, curing sickle cell disease brings us closer to someday weaponizing it.”

Kasper Mccarty • Charcuterie Arranger